INTRODUCTION:
The mitochondrial adenosine triphosphate (ATP) synthase is the enzyme responsible for the synthesis of more than 90% of the ATP produced by mammalian cells under aerobic conditions. The chemiosmotic mechanism, proposed by Peter Mitchell, states that the enzyme transduces the energy of a proton gradient, generated by the electron transport chain, into the major energy currency of the cell, ATP. The enzyme is a large (about 600,000 Da, in the monomer state) multisubunit complex, with a water soluble complex (F 1 ) that contains three active sites and a membrane complex (F o ) that contains the proton translocation pathway, principally comprised of the a subunit and a ring of 10 c subunits, the c 10 -ring (10 in yeast, 8 in mammals). F 1 has a central rotor that, at one end, is within the core of F 1 and, at the other end, is connected to the c 10 -ring of F o . During ATP synthesis, the c 10 -ring rotates, driven by the movement of protons from the cytosol to the mitochondrion, and in turn, the rotor rotates within F 1 in steps of 120 o . The rotation of the rotor causes conformational changes in the catalytic sites, which provides the energy for the phosphorylation of adenosine diphosphate (ADP), as first proposed in the bindingchange hypothesis by Paul Boyer. The peripheral stalk acts as a stator connecting F 1 with F o and prevents the futile rotation of F 1 as the rotor spins within it.
RATIONALE: Structural studies of the ATP synthase have made steady progress since the structure of the F 1 complex was described in pioneering work by John Walker. However, obtaining a high-resolution structure of the intact ATP synthase is challenging because it is inherently dynamic. To overcome this conformational heterogeneity, we locked the yeast mitochondrial rotor in a single conformation by fusing a subunit of the stator with a subunit of the rotor, also called the central stalk. The engineered ATP synthase was expressed in yeast and reconstituted into nanodiscs. This facilitated structure determination by cryo-electron microscopy (cryo-EM) under near native conditions. RESULTS: Single-particle cryo-EM enabled us to determine the structures of the membraneembedded monomeric yeast ATP synthase in the presence and absence of the inhibitor oligomycin at 3.8-and 3.6-Å resolution, respectively. The fusion between the rotor and stator caused a twisting of the rotor and a 9°rotation of the c 10 -ring, in the direction of ATP synthesis, relative to the putative resting state. This twisted conformation likely represents an intermediate state in the ATP synthesis reaction cycle. The structure also shows two proton half-channels formed largely by the a subunit that abut the c 10 ring and suggests a mechanism that couples transmembrane proton movement to c 10 -ring rotation. The cryo-EM density map indicates that oligomycin is bound to at least four sites on the surface of the F o c 10 -ring that is exposed to the lipid bilayer; this is supported by binding free-energy molecular dynamics calculations. The sites of oligomycinresistant mutations in the a subunit suggest that changes in the sidechain configuration of the c subunits at the a-c subunit interface are transmitted through the entire c 10 -ring.
CONCLUSION:
Our results provide a high-resolution structure of the complete monomeric form of the mitochondrial ATP synthase.
The structure provides an understanding of the mechanism of inhibition by oligomycin and suggests how extragenic mutations can cause resistance to this inhibitor. The approach presented in this study paves the way for structural characterization of other functional states of the ATP synthase, which is essential for understanding its functions in physiology and disease. † David M. Mueller 1 † Mitochondrial adenosine triphosphate (ATP) synthase comprises a membrane embedded F o motor that rotates to drive ATP synthesis in the F 1 subunit. We used single-particle cryo-electron microscopy (cryo-EM) to obtain structures of the full complex in a lipid bilayer in the absence or presence of the inhibitor oligomycin at 3.6-and 3.8-angstrom resolution, respectively. To limit conformational heterogeneity, we locked the rotor in a single conformation by fusing the F6 subunit of the stator with the d subunit of the rotor. Assembly of the enzyme with the F6-d fusion caused a twisting of the rotor and a 9°rotation of the F o c 10 -ring in the direction of ATP synthesis, relative to the structure of isolated F o . Our cryo-EM structures show how F 1 and F o are coupled, give insight into the proton translocation pathway, and show how oligomycin blocks ATP synthesis.
T he mitochondrial adenosine triphosphate (ATP) synthase is composed of two distinct molecular motors, F 1 and F o ( Fig. 1 and Movie 1). F 1 includes three catalytic subunits around a central rotor that rotates to effect ATP synthesis. F o is a transmembrane proton turbine that includes the c 10 -ring, a ring of 10 c subunits, which rotates in steps of 36°as it moves protons from the cytosol to the matrix space, down an electrochemical gradient (1). The c 10 -ring in F o is physically coupled to the rotor in F 1 , and therefore, proton translocation drives the synthesis of ATP. F 1 is held in place by a peripheral stator that prevents the rotation of the body of F 1 and restricts the wobbling of its central rotor relative to the c 10 -ring. Relative to the stator, the F 1 rotor can be in three distinct positions (rotomers), whereas a revolution of the c 10 -ring involves 10 discrete steps. This combination of 120°steps of the rotor and 36°steps of the c 10 -ring results in multiple conformations of the ATP synthase during the reaction cycle. Furthermore, the ATP synthase can form homodimers (2-4), which further increases the number of possible conformations of the enzyme complex, making the analysis of the reaction mechanism on a molecular level challenging. Here we have used a genetic method to restrict the number of conformations, allowing us to study the monomeric form of the yeast ATP synthase. We reconstituted the monomeric enzyme complex into a lipid bilayer formed in nanodiscs to enable structural analysis under near native conditions.
To restrict the number of conformations, we genetically fused subunit F6 of the stator to the d subunit of the rotor. The subunits were linked by T4 lysozyme, giving a final fusion of H 2 N-F6-lysozyme-d-CO 2 H (fig. S1 ). The mitochondrial leader peptide from the b subunit (ATP2) was added to direct the import of the protein into the mitochondria, and the expression was controlled with the ATP2 transcriptional elements. The plasmid containing this fusion was integrated into the genome of a yeast strain that is devoid of the genes encoding F6 (ATP14) and the d subunit (ATP16). The gene encoding ATP2 was also deleted in the strain, but this was complemented by integration of a vector into the genome that contains the b subunit with a His 6 tag on the amino terminus, allowing rapid purification of the enzyme.
We performed single-particle cryo-electron microscopy (cryo-EM) analysis on the nanodiscreconstituted ATP synthase both with and without the inhibitor oligomycin. Three preparations of nanodiscs (5) were used, which differed in their lipid content (see methods). Overall, the cryo-EM density that gave rise to the model of the F 1 F o ATP synthase was more complete under the conditions with oligomycin than without, but the structures were similar. Thus, we will confine the discussion of the overall structure to the structure with bound oligomycin.
To allow analysis of the proton translocation mechanism, the refinement was focused on F o , which improved resolution of this region but also resulted in poorer resolution of the other parts of the enzyme. For the F o regions, we compare the structures with and without bound oligomycin.
Overall structure of the ATP synthase
The cryo-EM structures of the yeast ATP synthase in nanodiscs were determined to overall resolutions of 3.6-and 3.8-Å for the entire enzyme complex in the absence or presence of oligomycin, respectively (see Fig. 2 , Table 1 , and figs. S1 to S5). The EM density for F o is weaker and of lower resolution than that of F 1 , likely owing to flexibility between these domains. Hence, F ofocused three-dimensional (3D) classification and refinement improved the resolution and map quality. In the presence of oligomycin, the flexibility of the ATP synthase was reduced, resulting in better EM density for F o and the stator and a greater number of residues in F o with welldefined side-chain densities. The resolution varied between subunits and within subunits. Most residues in the F 1 subunits display excellent sidechain density, whereas the stator and F o subunits showed varying resolutions. Many good side-chain densities could be seen for most of the components present in the cryo-EM structures, including the central stalk and c 10 -ring. The secondary structural elements are also well resolved for the stator components. We were able to trace 27 chains in the density (Fig. 3A , Movie 2, and Table 2 ). The only chains that we did not see are those involved in dimerization of the ATP synthase (as this is the monomer form). The density for the T4 lysozyme molecule used to fuse F6 with d is seen in one of the cryo-EM maps from 3D classification (fig. S3C ). Low-resolution density for the lipid nanodisc clearly delineates the membrane-embedded regions of F o (Fig. 2) .
There are three catalytic sites in F 1 , each of which cycles between three states. In the first highresolution crystal structure of the F 1 ATPase, the sites were occupied with adenosine diphosphate (ADP) or ATP and one site was empty, and thus they were named DP, TP, and E, respectively (Table 2) (6). The asymmetry of the catalytic sites is determined by the relative position of the g subunit within F 1 . In our cryo-EM structures, the rotor is in a single orientation, and the asymmetry of the catalytic sites is conserved. In this orientation, the stator bridges F o with F 1 along the noncatalytic site formed by chains B (a TP ) and E (b DP ). There is contact between subunit d of the stator with a TP (chain B).
The F 1 domain
The conformation of the yeast F 1 domain in the cryo-EM structures is nearly identical to that observed in the crystal structures of yeast F 1 (7) or yeast F 1 -c 10 (8, 9) , which also revealed the three distinct states of the catalytic sites DP, TP, and E. When we superimpose yeast F 1 onto the structure of yeast F 1 F o , we see that the rotor formed by the g, d, and e subunits is twisted by about 9°i n the direction of the rotation that leads to ATP synthesis (Fig. 3B) . The twisting starts at about g-Ile
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, which is in direct contact with the collar formed by the a and b subunits (6) . At the bottom of the rotor, this twisting results in a displacement of about 5.6 Å in residues in the d subunit. This displacement continues into the c 10 -ring and causes a commensurate rotation of the c 10 -ring relative to the a subunit in F o (Fig. 3C ). Although we believe that the constraint of the central stalk with the stator can mimic the twisting of the central stalk during the reaction cycle, this is a first approximation and has not been proven.
The stator domain
The stator (peripheral stalk) is composed of subunits OSCP (oligomycin sensitivity conferral protein), b, d, F6, f, i/j, and 8. Subunits OSCP, b, d, f, and F6 primarily serve as structural components of the stator. However, subunits b, d, f, i/j, and 8 are either embedded or attached to the membrane and are part of the complex purified as F o ; they may have a role in proton movement in addition to a structural role in forming the stator. Subunits b and d are similar to their homologs in the crystal structure of bovine subunits F6, b, and d [Protein Data Bank (PDB) 2CLY] (10); however, yeast F6 displays differences from bovine F6, including an additional helix (residues 76 to 91) at the C terminus, which adds additional interactions with the b and d subunits. Modeling of the domains of stator subunits that are part of F o and embedded or bound to the membrane was aided by the high-resolution cryo-EM structure of yeast F o (PDB 6B2Z) (11), and we did not see any major differences as compared to the reported structure.
The OSCP subunit anchors the stator at the top of F 1 . As partially seen in the structure of the enzyme from the yeast Pichia angusta (12) , the N terminus of the three a subunits interact to stabilize the binding of OSCP to the top of F 1 ( fig. S7 ). The helix in a TP (chain B) formed from BLys 4 to BAsn 26 interacts with helices from F6 and the b subunit ( fig. S7, region I) . Furthermore, the three-helix bundle formed by residues B462 to B509 interact with two helices of the d subunit from residues 3 to 48, and a cluster of residues in OSCP ranging from 160 to 168 as well as residue 122 (region I). Residues in a random coil from a DP (chain C, Gln 6 The a subunit is adjacent to the c 10 -ring and contributes to form the proton-conduction pathway from the cytosolic side of the mitochondria to protonation sites in the c 10 -ring and from these sites to the matrix space (13) (14) (15) . The protonation and deprotonation events at the interface between the a subunit and the c 10 -ring couple the translocation of protons to the rotation of the c 10 -ring and thus effect ATP synthesis. We obtained the near-atomic resolution F o maps for the enzyme without bound oligomycin and with oligomycin, and the structural models from these maps are nearly identical. This suggests that oligomycin binding does not alter the overall structure of F o .
The structure of the c 10 -ring is nearly identical to that observed in a crystal structure of the isolated ring (16) is the proton acceptor and donor that is responsible for net proton movement during the catalytic cycle. The side chain of Glu 59 has been shown to be in one of two conformations: a "closed" conformation, which was suggested to represent the protonated form when in the membrane, and an "open" conformation, which was proposed to be present only at the a-c interface and to represent the state in which protonation and deprotonation occurs (16, 17) . We see four instances where Glu 59 is in the open conformation in the membrane phase, suggesting that the closed conformation is not a necessary conformation of the protonated side chain in the membrane phase (fig. S8) .
The structure of dimeric yeast F o was solved by cryo-EM after stripping off F 1 by using NaBr (11) . This structure likely represents the "ground state," as it is free from strain caused by assembly of the F 1 F o ATP synthase complex. We superimposed the F o region from the ground state onto the F o region from our native structures using the a and b subunits as the anchor (Fig. 3C ). This analysis indicates that the c 10 -ring of the native structure, relative to the a subunit, is rotated about 9°in the direction of ATP synthesis, as compared to the ground state. This is consistent with the rotation that we observed in the F 1 rotor, when comparing our structure to that of F 1 alone.
Arg 176 of the a subunit is the only residue that is strictly conserved (13) (fig. S9 ). It has been proposed that Arg 176 prevents the short-circuiting of protons in the proton pathway (18) as well as acting as a positive pole for attraction of the charged Glu 59 (14) . In the isolated F o structure (11) ) are separated by 5 to 7.5 Å, whereas in our structure, the side chains move closer, to within 3.8 Å (Fig. 3D) . Extrapolation on the movement of the c 10 -ring in the direction of ATP synthesis would predict an even closer configuration of Arg 176 and Glu 59 , thereby creating a potential contributing force for rotation of the c 10 -ring. This attractive force will be much reduced once the ionized cGlu 59 is protonated.
The proton pathway
During ATP synthesis, protons transit from the cytosolic side of the mitochondrial membrane to protonate the c-subunit Glu 59 closest to Arg ), thereby releasing this interaction. Protons must be released from c 1 Glu 59 into the matrix space (Fig. 4A) , although not necessarily in concert with protonation, enabling this side chain to engage Arg 176 following a 36°step. The hydrophilic spaces that provide pathways for protons from the cytosol and then to the matrix space, allowing protonation and later deprotonation of cGlu 59 , are referred to as half-channels. Figure 4 and Movie 3 show the putative halfchannels from the cytoplasm and to the matrix. Their location and identification is consistent with recent reports (11, (19) (20) (21) . The matrix-side half-channel is most obvious at the a-c interface, where the side chains of a number of residues appear to form a hydrophilic cavity that extends from c 1 Glu 59 to the surface of the membrane phase (Fig. 4, A, C, and D) . aGlu 162 is an important, but not essential, residue in this pathway (13) . The matrix half-channel extends up to the point that we have determined to be the edge of the membrane. By contrast, the cytoplasmic half-channel is formed by residues in the f, b, and a subunits. The protonconduction pathway appears to include aHis 185 and aGlu 223 (Fig. 4, A and B) . The proton-conduction pathway proceeds between helices 5 and 6 of the a subunit. aHis 185 and aGlu 223 are interchanged in the enzymes from other species but remain in comparable positions (fig. S9) A requirement for a proton donor or acceptor in the reaction pathway is that the value of the pK a (where K a is the acid dissociation constant) of the donor and acceptor should be around the pH of the medium. The pH of the cytosol is around 7.0, whereas that of the matrix space during active ATP synthesis is around 8.0. Thus, the pK a of the carboxyl of cGlu 59 should be around 7.0 at the a-subunit interface to be an effective proton carrier. If the pK a of the carboxyl was the standard value in water, 5.0, then the carboxyl would rarely be in the protonated state, and rotation would be severely impeded during ATP synthesis. Although a low pK a would allow the release of the proton to the matrix space during ATP synthesis, it would impede the reversal of the ATP synthase reaction-ATP hydrolysiswhich is a fundamental feature of the enzyme. Thus, the pK a of the cGlu 59 must be around 7.0 at both the sites for protonation and deprotonation to occur during ATP synthesis and hydrolysis. Although there is a report that the pK a of the c-ring carboxylate is 7.0 (22), these measurements were not made under native conditions nor measured in the intact enzyme. On the basis of the structure, we suggest that aGlu 162 59 have the potential to shift the pK a of the side-chain cGlu 59 up to around 7.0, where it needs to be to act as an effective protontransfer group. There is precedence for glutamateglutamate interactions and histidine-glutamate interactions altering the pK a of carboxylates to around 7.0 (23) (24) (25) (26) . This hypothesis is consistent with biochemical data that show that replacements at these two positions alter the magnitude of the potential gradient that the enzyme can create with the hydrolysis of ATP (13, 27, 28) . Of course, this is still hypothetical, and proof will require the structure determination of multiple intermediate states of the reaction cycle.
Inhibition by oligomycin
The crystal structure of the isolated yeast c 10 -ring with bound oligomycin has been determined at 1.9 Å (PDB 4F4S) (29) . Oligomycin was shown to bind to the c 10 -ring with the inhibitor spanning the outer helices of two adjacent c subunits and centered over cGlu 59 . It has been unclear whether oligomycin would bind to the c 10 positioned in the membrane phase and at the same position where oligomycin was seen to bind in the crystal structure of the c 10 -ring (29) (Fig. 5A) . The density map for oligo1 to oligo4 suggests that there is some variation in the binding strength at each site. This may reflect slight differences in the conformation of the main and side chains at each binding site. There is also weak density at c 4 c 5 , which is at the edge of the a-c interface, but the best fit to the density with an oligomycin molecule (oligo5) places oligomycin in a much different binding mode as compared to those in the other sites ( fig. S11) . Furthermore, the conformation of oligo5, as modeled, is largely different from that observed previously. Likely, the weak density attributed to oligo5 is due in part to surrounding lipid molecules. Thus, we believe that this, at best, represents a minor binding mode.
To test the hypothesis that oligomycin can bind in a stable mode to the c 10 -ring in a membrane environment, we evaluated the free energy of formation of this complex using all-atom molecular dynamics simulations ( fig. S12 ). This binding free energy can be defined as DG b = -k B T ln N + DG int + DG r + DG t , where k B is the Boltzmann constant, T is temperature, N is the number of available binding sites on the c 10 -ring, DG int is the free-energy difference between the associated and dissociated complex, and DG r and DG t are the free-energy penalties due to the loss of rotational and translational entropy of the inhibitor upon binding, respectively. The values calculated from the simulation data are (detailed in methods) DG int = -6.6 kcal/mol, DG r = +1.6 kcal/mol, and DG t = +4.4 kcal/mol, where the latter assumes that the mole fraction of oligomycin in the membrane is 0.01. For N = 7 (that is, the number of c subunits exposed to the membrane), the resulting value of the binding free energy, DG b = -1.7 kcal/mol, implies that oligomycin is about 20 times more likely to be bound to the c 10 -ring than free in the lipid bilayer. (Note that DG t would be reduced for higher oligomycin densities, and thus binding would be more favorable. For a mole fraction of 0.05, DG t is +3.5 kcal/mol, and DG b would range from -2.7 kcal/mol for N = 7 to -1.5 kcal/mol for N = 1, which translate into binding probabilities ranging from 90:1 to 10:1.) This energetic analysis hence supports the conclusion that oligomycin binds to the c 10 -ring subunits exposed to the lipid bilayer. All available data therefore suggest that oligomycin inhibits the enzyme by first binding to the c 10 -ring and thus impairs its rotation against subunit a. Likely, the c subunit with bound oligomycin is sterically prevented from entering the a-c interface, but, if it did, it would be unable to either release the bound proton or accept a proton during the catalytic cycle.
There (Fig. 5, B to D) . This poses a paradox, in that these mutations map to locations that are separated by as many as 61 residues along a single a helix and distant from the binding sites mapped on the c 10 -ring. However, the resistance-forming residues all face the c 10 -ring and are positioned almost at the center of the region where oligomycin is known to bind, though not at those specific sites. These bulky replacements in the a subunit will disrupt the c 10 -ring at the point of their interaction but, in doing so, also disturb the interaction between the neighboring two c subunits. We propose that the disruption in the conformation of the c 10 -ring, possibly just on the surface, is propagated through all c subunits, thereby allowing a stable c 10 -ring and altering the conformation of all oligomycin binding sites. As such, the conformation of the wild-type c subunit (represented here as cO S ) is converted to a conformation that is resistant to oligomycin, cO R . However, for a c 10 -ring to form, each subunit must have identical contacts between the c 10 -ring, and thus c 1 O R c 9 O S gets converted to c 10 O R (where the subscript represents the number of c subunits) in the presence of the oligomycin-resistance mutation in the a subunit. This suggests that the conformation of the c 10 -ring surface is plastic, in that it can assume new stable forms that allow it to function. This represents a mechanism that differs from allosteric interactions as they are normally thought of in relationship to enzyme regulation.
Materials and methods

Yeast strains and plasmids
Yeast wild type, USY006 (Mata, ade2-1, his3-11,15, leu2-1, trp1-1, ura3-52, atp2::LEU2, pRS304-ATP2H6::TRP1) and yeast with F6d fusion, DMY741 (Mata, ade2-1, his3-11,15, trp1-1, ura3-52, can1 R 100, atp2::loxP, atp7::loxP, atp1::KANR, F6d::LEU2, ATP2-H6::TRP1, ATP1::URA3) were used throughout. pMSP1E3D1 (31) was a gift from Stephen Sligar (Addgene plasmid # 20066) and was transformed into BL21 (DE3) Gold (Agilent, Santa Clara, CA). Plasmid pRK792 (32) (to express TEV protease) was a gift from David Waugh (Addgene plasmid # 8830). The yeast was grown in a 60l fermentor in semisynthetic media with the glucose concentration controlled to about 0.2% (33) . Bacteria were grown in LB media.
The parent strain for DMY741 was W303-1A (Rodney Rothstein via Alex Tzagoloff, Columbia University). Strain DMY741 was developed by sequentially deleting out the genes (34), ATP1, ATP2, ATP7, and ATP16 and then introducing the genes on plasmids containing ATP1, ATP2 with a His 6 tag, and the fusion construct contain subunit F6 (ATP7), T4-lysozyme, and the d subunit (ATP16). The fusion construct was made by total synthesis of the DNA (Genscript, Piscataway, NJ). The DNA sequence that encoding T4 lysozyme was codon optimized for expression in yeast and was flanked Srivastava et al., Science 360, eaas9699 (2018) 11 May 2018
5 of 8 by two NarI sites that added Gly-Ala to the N and C termini of lysozyme. The assembled gene was used in a "gap repair" reaction to introduce it into the gene encoding the b subunit such that it was inserted just behind the codons encoding the mitochondrial leader peptide on the 5′ end and then at the stop codon on the 3′ end of the gene, as described (35) . The fusion gene was subcloned into the integrating vector, pRS304 (36) and transformed (37) into the yeast strain.
Biochemistry
We chose to incorporate the yeast ATP synthase into nanodiscs as this is under near native conditions and the oligomycin binding site is at the surface of the c 10 -ring in the membrane phase.
Yeast ATP synthase was purified essentially as described except a Co-affinity column was substituted for the Ni-affinity column (33) . For reconstitution of the ATP synthase into nanodiscs, the enzyme was purified only through the Co-affinity column.
The membrane scaffolding protein (MSP), MSP1E3D1, was expressed in BL21-Gold (DE3) strain (Agilent, Santa Clara, CA) as described (38) For reconstitution of F 1 F o into nanodiscs, we used three different lipid preparations. In the case of the structural analysis in the absence of oligomycin, we used nanodiscs prepared form total polar E. coli lipids spiked with ergosterol at a ratio of 3:1 on a molar basis, and we also used 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC). For the structure in the presence of oligomycin, we used 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) mixed with cardiolipin (C:18) (CL), at a ratio of 3:1 by weight. The lipids were (obtained from Avanti Polar Lipids, Alabaster, Al) dissolved in chloroform, and stored under argon at -80°C.
The most improved method for reconstitution is reflected in the preparation using POPC: CL. In this procedure, the lipids were added to a glass test tube and the chloroform was removed with a gentle stream of nitrogen. The sample was placed under vacuum for overnight to remove the residual chloroform. The lipids were dissolved in 20 mM Tris-Cl, 0.15 M NaCl, pH 7.4 with 60 mM DDM with the aid of a water bath sonicator. Solubilized lipid was mixed with MSP1E3D1 and F 1 F o ATP synthase at a molar ratio of 120:15:2.5 (lipid:MSP:F 1 F o ) and the mixture was incubated at 30°C for 1 hour with constant agitation. To initiate nanodisc assembly, Amberlite XAD-2 (Sigma Aldrich, Milwaukee, WI) beads (0.6 g/ml, final) were added and the mix was incubated at 30°C for 24 hours with constant agitation. Adsorbent beads were added in three batches; in first batch 8% of total beads were added and the reaction was incubated for 6 hours; in the second batch, additional 10% of total beads were added and the reaction mix was incubated for another 16 hours; in the final step of addition, the final 82% of total beads were added and the reaction was incubated for another 2 hours. For reconstitution using E. coli total polar lipids or DMPC, the adsorbent beads were added in four batches, 25% of the total beads per hour for a total of 4 hours. The beads were removed and the reaction mixture was purified on a Superose-6 (GE Healthcare, Uppsala, Sweden) size exclusion column equilibrated with 20 mM Tris-Cl, 50 mM sucrose, 4 mM MgSO 4 , 1 mM EDTA, 0.25 mM ADP, 0.15 M NaCl, 5 mM e-amino caproic acid and 5 mM benzamidine HCl, 1 mM PMSF, pH 8.0. The buffer was exchanged using a centrifugal column (39) (1 ml) using Bio-Gel P-6 (Bio-Rad, Hercules, CA) and buffer containing, 20 mM Tris-Cl, 4 mM MgSO 4 , 1 mM EDTA, 0.25 mM ADP, 0.15 M NaCl, 5 mM e-amino caproic acid and 5 mM benzamidine HCl, 1 mM PMSF, pH 8.0. The specific activity (u/mg) and percent oligomycin sensitive ATPase using wildtype enzyme was 10:42, 59:78, and 55:85% for reconstitution using E. coli polar lipids, DMPC an POPC/CL, respectively.
Cryo-electron microscopy data acquisition
Purified yeast F 1 F o reconstituted in nanodiscs at the concentration of 1 mg/ml (2.5 ml) was applied to a glow-discharged Quantifoil holey carbon grid (1.2/1.3, 400 mesh), and blotted for 3 s with~91% humidity before plunge-freezing in liquid ethane using a Cryoplunge 3 System (CP3, Gatan). For cryo-EM of F 1 F o with oligomycin, 60 mM stock solution of oligomycin in dimethyl sulfoxide was added to a final concentration of 30 mM, and incubated on ice for 30 min. The mixture (2.5 ml) was applied to a grid, blotted and plunge-frozen. Cryo-EM data were recorded on a 300-kV Polara electron microscope (FEI) at Harvard Medical School. All cryo-EM movies were manually recorded with a K2 Summit direct electron detector (Gatan) in super-resolution counting mode using UCSFImage4 (40) . Details of the EM data collection parameters are listed in Table 1 . EM image processing EM data were processed as previously described (41) . Dose-fractionated super-resolution movies collected using the K2 Summit direct electron detector were binned over 2 × 2 pixels, and subjected to motion correction using the program MotionCor2 (42) . A sum of all frames of each image stack was calculated following a doseweighting scheme, and used for all imageprocessing steps except for defocus determination. CTFFIND4 (43) was used to calculate defocus values of the summed images from all movie frames without dose weighting. Particle picking was performed using a semi-automated procedure with SAMUEL and SamViewer (44) . Two-and three-dimensional (2D and 3D) classification and 3D refinement were carried out using "relion_ refine_mpi" in RELION (45) . Masked 3D classification focusing on F o with residual signal subtraction was performed following a previously described procedure (46) . All refinements followed the gold-standard procedure, in which two half data sets were refined independently. The overall resolutions were estimated based on the goldstandard criterion of Fourier shell correlation (FSC) = 0.143. Local resolution variations were estimated from two half data maps using ResMap. The amplitude information of the final maps were corrected by applying a negative B-factor using the program bfactor.exe.
Model refinement
The initial model was derived from the crystal structure of F 1 ATPase (PDB, 2WPD) and the c 10 -ring from our previous crystal structure (PDB 3U2F). Models for subunits OSCP, b, F6, and subunit d were initiated as homology models based on bovine structures (PDB, 2CLY and 5FIK). Models for subunits a, A6L/subunit 8, f, j, and the N-terminal part of subunit b were derived from the cryo-EM structure (PDB 6B2Z). Initial models were rigid-body fitted to our cryo-EM maps, extensively rebuilt in Coot (47) , and refined in Refmac (48) using the script refine_ local, and subsequently, using real-space refinement in Phenix (49) .
Final models were validated with statistics from Ramachandran plots, MolProbity scores, and EMRinger scores (Table 1) . MolProbity and EMRinger scores were calculated as described (50, 51).
Molecular dynamics simulations
All simulations were performed with NAMD2 (52), using CHARMM36 force-field for proteins and lipids (53, 54) , periodic boundary conditions, and constant temperature (298 K) and pressure (1 atm). Long-range electrostatic interactions were calculated using PME, with a real-space cut-off of 12 Å. Van der Waals interactions were computed with a Lennard-Jones potential, cutoff at 12 Å with a smooth switching function taking effect at 10 Å. Simulations were carried out for two systems: a complex of the yeast c 10 -ring with four oligomycin molecules bound (PDB 4F4S), embedded in a hydrated, pre-equilibrated 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatydylcholine (POPC) lipid bilayer; and a system of the same components, with one oligomycin molecule dissociated from the c 10 -ring and free in the lipid bilayer. Force-field parameters for oligomycin were derived using the GAAMP server (55) . The c 10 -ring complex was embedded in the POPC membrane using GRIFFIN (56) , as previously described (57) . Counter-ions were added to neutralize the charge of the simulation system. The simulation systems were equilibrated following a staged protocol whereby positional and conformational restraints acting of the proteininhibitor complex are gradually weakened over 200 ns. The equilibrated systems were then used as the starting point for the analysis of the oligomycin binding free energy.
The inhibitor binding free-energy was calculated as DG b = -k B T ln N + DG int + DG r + DG t , where N is the number of available binding sites on the c 10 -ring, DG int is free-energy difference between the associated and dissociated complex, and DG r and DG t denote the free-energy penalties due to the loss of rotational and translational entropy of the ligand upon binding, respectively (k B is the Boltzmann constant and T the temperature). DG int was, in part, derived from calculations of the free-energy change associated with decoupling oligomycin from the rest of the molecular system, in both the bound and unbound states. Analogous calculations were carried out whereby oligomycin is recoupled to the system. These calculations used the Free-Energy Perturbation method, whereby the decoupling and recoupling process is induced through a parameter l that scales the nonbonded interactions between the ligand and its environment. The parameter l varied gradually and step-wise between 1 and 0, and vice versa, in 54 consecutive simulations. For each value of l, in either direction, an incremental free-energy change was estimated from a simulation of 1 ns, after a 200-ps equilibration stage, in the case of bound oligomycin; for the dissociated ligand, the sampling and equilibration times per intermediate were 1.5 ns and 300 ps, respectively. The resulting values for this decoupling free-energy are 39.8 and 32.8 kcal/mol for the bound and unbound ligand, respectively. Intramolecular interactions thus result in a free-energy contribution that favors binding, i.e., DDG FEP = -7.0 kcal/mol.
For computational efficiency, during the abovementioned decoupling/recoupling simulations, the internal conformation of the oligomycin molecule considered was preserved using a harmonic RMSD restraint, defined relative to that in the equilibrated systems, with a force constant k = 9.6 kcal/mol Å 2 . Hence, DG int = DDG FEP + DDG RMSD , where the latter term is the difference in the free-energy cost of imposing the conformational restraint on the bound versus the unbound ligand. This contribution was computed separately, through an additional set of simulations whereby k is scaled down gradually, using a parameter a that varies step-wise from 1 to 0, and vice versa. Specifically, 50 simulations of 1 ns each were carried out in each direction for the bound and unbound states. From each of these simulation series, the value of DG RMSD can be derived using the expressions: When dissociated from the c 10 -ring, oligomycin adopts primarily an upright orientation, i.e., its rotational freedom relative to the membrane plane is restricted; however, the molecule rotates freely around the membrane perpendicular. The free-energy cost associated with the loss of rotational entropy upon binding can be therefore estimated as DG r = -k B T ln[Dq/2p], where Dq is the rotational fluctuation of the bound ligand perpendicularly to the membrane; from our simulations we estimate that Dq~0.44 rad (or 25 degrees), and thus DG r = 1.6 kcal/mol.
Similarly, to estimate the free-energy cost associated with the loss of translational entropy upon binding, we used the expression DG t = -k B T ln [D°DA] , where DA represents the translational freedom of the bound ligand on the membrane plane when bound to the protein, whereas D°is the ligand area-density in the surrounding medium, akin to the standard concentration C°used in the context of three-dimensional bi-molecular association. Although there is no analogous standard for D°, the mole fraction of the inhibitor in the lipid membrane may be used to define a reference state. For example, an assumed mole fraction of 0.01, i.e., 1 inhibitor per 100 lipids, translates into D°= 7,000 Å 
Primary sequence analysis
Primary sequence alignment was done using COBALT (58) .
Figure images
Many of the images presented in the figures were made with the assistance of Pymol (59) .
